1-3 of 3
Hiromitsu Iizuka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Survival with Venetoclax in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Cohort Study

Yoshimasa Kamoda, Masako Hirao, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki, Motoshi Ichikawa
Journal: Blood
Blood (2023) 142 (Supplement 1): 5936.
https://doi.org/10.1182/blood-2023-173795
Published: 2023
Journal Articles

An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Shinya Kimura, Kensuke Usuki, Tatsuo Ichinohe, Takayuki Ikezoe, Junya Kuroda, Senji Kasahara, Sho Okamoto, Hiromitsu Iizuka, Hiroshi Ureshino, Tatsuro Watanabe, Tokihiro Ro, Kosuke Endo, Yuka Kagawa, Yuki Kurahashi, Toshiki Naito, Takahiro Yamauchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6466.
https://doi.org/10.1182/blood-2023-173174
Published: 2023
Journal Articles

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Yoshimasa Kamoda, MD, Akira Hangaishi, MD PhD, Hiroki Hayashida, MD, Yusuke Uchibori, MD, Hiromitsu Iizuka, MD PhD, Michiko Kida, MD PhD, Kensuke Usuki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3981.
https://doi.org/10.1182/blood-2018-99-111123
Published: 2018